Sources | Names Used |
---|---|
GDSC1000, FIMM | Bexarotene |
CTRPv2 | bexarotene |
PharmacoGx | Bexarotene |
Database | Identifier |
---|---|
Smiles: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
Inchikey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Pubchem: | 82146 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAPTM4B | FIMM | pan-cancer | AAC | 0.5 | 0.004 |
mRNA | SH2B2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | PLEK | FIMM | pan-cancer | AAC | 0.71 | 0.004 |
mRNA | TEAD1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | TACC1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | DPF1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | ASXL3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | WDFY2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | MRPL35 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | EIF4A3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |